The GA²LEN ANACARE series of webinars (still available on-demand) at https://ga2lenwebinar.online was held regularly during 2021, to fill the unmet needs of health care providers. The GA²LEN ANACARE faculty included in these webinars are key opinion leaders in the field of anaphylaxis and related subtopics pertaining to this complex and widespread disease. The needs assessment included in this program supports participants to fill the gaps and their knowledge regarding patients at risk of anaphylaxis.
Anaphylaxis is a complex disease which requires all aspects of its burden to be understood. Not only the physical burden but also the one related to sociological well-being, mental well-being, and self-medication need appropriate evaluation.
The GA²LEN ANACARE series of webinars (now available on-demand) at https://ga2lenwebinar.online was held regularly during the year, to fill the unmet needs of health care providers. The first series was devoted to Anaphylaxis.
The ANACARE webinars were provided to reach out to colleagues on a global level, facilitating attendance despite the time zone differences.
Browse all 10 webinars in this exciting and informative series and have a look through the ANACARE Webinar program.
For each webinar a learning objective was set out and met, including an evaluation performed at the end of each webinar.
An interactive learning discussion with Q&A was supported, where health care providers could discuss and secure the knowledge that they gained during this educational online event. Participants were encouraged to ask the faculty questions and participate actively in this online discussion in order to fortify their knowledge. This was then be put into immediate effect within their own daily practice.
We were delighted to be able to welcome you in the Training Course and to share with you this exciting journey inside anaphylaxis.
Torsten Zuberbier, Antonella Muraro, Margitta Worm and Carsten Bindslev -Jensen
The GA²LEN President & ANACARE Steering Committee
This Program is supported by an unrestricted grant from Viatris